The New York Times reports that the number of children on medication for attention deficit disorder has soared to 3.5 million from 600,000 in 1990. The rise of AHDH diagnoses and prescriptions for stimulants has coincided with a remarkably successful two-decade campaign by pharmaceutical companies to publicize the syndrome and promote the pills to doctors, educators and parents.